Chad J.  Wasserman net worth and biography

Chad Wasserman Biography and Net Worth

Chad Wasserman is senior vice president and chief information officer of HCA Healthcare, one of the nation’s leading providers of healthcare services.

A 28-year veteran of HCA Healthcare, Wasserman leads more than 6,700 colleagues in the Information Technology Group (ITG), which provides global IT strategy solutions and support for HCA Healthcare and its hospitals and sites of care. He oversees the group’s array of solutions including infrastructure, cloud, automation, data engineering, software development, enterprise systems and clinical technology initiatives.  

Previously Wasserman served as senior vice president and chief operating officer for ITG, after serving as VP ITG Service Line and Corporate Solutions. He has served in a variety of senior leadership positions for the company including vice president ITG Digital Patient Experience and vice president ITG Infrastructure Services and Operations. Prior to 2017, Chad was CIO of Parallon Business Performance Group.

He currently serves on the Executive Committee of the Nashville Technology Council. Wasserman is an HCA Healthcare Hope Fund board member and sits on the Belmont University Business Solutions and Analytics Advisory Board.

Wasserman earned his bachelor’s degree in political science from Villanova University and his master’s degree in business administration from Tennessee State University.

What is Chad J. Wasserman's net worth?

The estimated net worth of Chad J. Wasserman is at least $524,808.00 as of March 20th, 2024. Mr. Wasserman owns 1,576 shares of HCA Healthcare stock worth more than $524,808 as of November 20th. This net worth estimate does not reflect any other assets that Mr. Wasserman may own. Learn More about Chad J. Wasserman's net worth.

How do I contact Chad J. Wasserman?

The corporate mailing address for Mr. Wasserman and other HCA Healthcare executives is ONE PARK PLAZA, NASHVILLE TN, 37203. HCA Healthcare can also be reached via phone at (615) 344-9551 and via email at [email protected]. Learn More on Chad J. Wasserman's contact information.

Has Chad J. Wasserman been buying or selling shares of HCA Healthcare?

Chad J. Wasserman has not been actively trading shares of HCA Healthcare during the past quarter. Most recently, Chad J. Wasserman sold 876 shares of the business's stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $330.25, for a transaction totalling $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares of the company's stock, valued at $520,474. Learn More on Chad J. Wasserman's trading history.

Who are HCA Healthcare's active insiders?

HCA Healthcare's insider roster includes Erol Akdamar (Insider), Jennifer Berres (SVP), Phillip Billington (SVP), Jeffrey Cohen (SVP), Michael Cuffe (Insider), Jane Englebright (SVP), Jon Foster (Insider), Thomas Frist, Jr. (Major Shareholder), Charles Hall (Insider), Samuel Hazen (CEO & Director), Michael McAlevey (SVP), Timothy McManus (Insider), Sandra Morgan (SVP), A. Morre, Jr. (Insider), Sammie Mosier (Senior Vice President and Chief Nurse Executive), P. Paslick (SVP), Jonathan Perlin (CMO), Deborah Reiner (SVP), Wayne Riley (Director), Bill Rutherford (CFO), William Rutherford (Exec. VP & CFO ), Andrea Smith (Director), Joseph Sowell, III (SVP), Kathryn Torres (SVP), Chad Wasserman (SVP), Robert Waterman (SVP), Kathleen Whalen (SVP), and Christopher Wyatt (SVP). Learn More on HCA Healthcare's active insiders.

Are insiders buying or selling shares of HCA Healthcare?

During the last twelve months, insiders at the sold shares 18 times. They sold a total of 51,236 shares worth more than $17,305,720.38. The most recent insider tranaction occured on November, 14th when SVP Phillip G Billington sold 3,897 shares worth more than $1,363,950.00. Insiders at HCA Healthcare own 1.7% of the company. Learn More about insider trades at HCA Healthcare.

Information on this page was last updated on 11/14/2024.

Chad J. Wasserman Insider Trading History at HCA Healthcare

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/20/2024Sell876$330.25$289,299.001,576View SEC Filing Icon  
3/18/2024Sell344$321.97$110,757.682,452View SEC Filing Icon  
2/2/2024Sell652$312.04$203,450.08290View SEC Filing Icon  
See Full Table

Chad J. Wasserman Buying and Selling Activity at HCA Healthcare

This chart shows Chad J Wasserman's buying and selling at HCA Healthcare by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HCA Healthcare Company Overview

HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $333.00
Low: $327.88
High: $335.61

50 Day Range

MA: $381.99
Low: $333.00
High: $415.67

2 Week Range

Now: $333.00
Low: $245.84
High: $417.14

Volume

1,426,476 shs

Average Volume

1,189,091 shs

Market Capitalization

$84.35 billion

P/E Ratio

14.95

Dividend Yield

0.77%

Beta

1.68